Tracking Wound Infection With Smartphone Technology (TWIST)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02704897|
Recruitment Status : Recruiting
First Posted : March 10, 2016
Last Update Posted : February 15, 2019
|Condition or disease||Intervention/treatment||Phase|
|Surgical Site Infection||Other: Wound Assessment Tool||Not Applicable|
Surgical site infection (SSI) is defined by the Centre for Disease Control and Prevention (CDC) as an infection in the skin and soft tissues of a surgical wound, within 30 days of the operation. It is a common problem, and complicates 2-10% of general surgery operations. The majority of cases are diagnosed outside of hospital and can be treated with oral antibiotics.
Interest in the use of technology in medicine is increasing, with the potential that more advanced technology will help facilitate communication between clinicians and patients, aid in the assessment of patients, and improve clinical decision making. Over two-thirds of people now own smartphones, and regularly use them to access the internet. The investigators wish to use a smartphone delivered questionnaire to help assess SSI and see if this improves access to care and time to treatment.
The investigators will be recruiting emergency surgery patients with smartphones at the Royal Infirmary and Western General Hospitals in Edinburgh.
Participants will be divided into two groups. One group will receive the wound assessment tool, if they are concerned about their wound, they can use the tool to answer a series of questions. If their answers suggest SSI, a clinician will contact them to advise further assessment and treatment. The participants will also be asked to respond to the tool three times during the trial (to collect responses from those without symptoms), and upload photos of their wounds to a secure database.
The second group of participants will receive normal post-operative care.
After 30 days, participants will have a follow-up consultation, to determine if they have had a wound infection (this can be via telephone or face-to-face, according to participant preference). They will also answer questions about their experience of the study, and use of services.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||500 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Can a Smartphone-delivered Tool Facilitate the Assessment of Surgical Site Infection, and Result in Earlier Treatment? A Randomized-controlled Trial in Emergency Surgery Patients.|
|Study Start Date :||July 2016|
|Estimated Primary Completion Date :||June 2019|
|Estimated Study Completion Date :||July 2019|
Experimental: Intervention Arm
Wound assessment tool - delivered via a smartphone. A link will be sent to participants on discharge, which can be accessed at any point should they have concerns about their wound.
They will also be sent the tool at 3 additional time-points.
Other: Wound Assessment Tool
A set of questions relating to the symptoms of wound infection
No Intervention: Control Arm
Normal Post-operative Care
- Time from surgery to treatment for surgical site infection [ Time Frame: Outcome assessed at 30 day follow-up ]Measured in days from surgery to commencing antibiotic treatment
- Service Usage [ Time Frame: Assessed at 30 day follow-up ]Number of attendances at General Practice (GP) and Accident and Emergency (A&E).
- Access to Services [ Time Frame: Assessed at 30 day follow-up ]How long in days between experiencing first symptom and being reviewed by A&E, GP or surgical team
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02704897
|Contact: Ewen Harrison, BM CHB||0131 242 firstname.lastname@example.org|
|Royal Infirmary Edinburgh||Recruiting|
|Edinburgh, United Kingdom, EH16 4SA|
|Contact: Ewen M Harrison, BMBCH 0131 242 3616 email@example.com|
|Western General Hospital||Recruiting|
|Edinburgh, United Kingdom, EH4 2XU|
|Contact: Mark Potter, MBCHB firstname.lastname@example.org|
|Principal Investigator:||Ewen Harrison, BM CHB||University of Edinburgh|